Search
for
Sort by
Research 91–120 of 1000+
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- Platelet-Rich Plasma in Alopecia Areata—A Steroid-Free Treatment Modality: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- Rethinking the classification of alopecia areata
- Successful treatment of resistant alopecia areata with a phototoxic dose of ultraviolet A after topical 8‐methoxypsoralen application
- Janus Kinase Inhibitors for Alopecia Areata
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Response of alopecia areata of the beard to oral tofacitinib
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata
- Dietary Habits in Japanese Patients with Alopecia Areata
- European expert consensus statement on the systemic treatment of alopecia areata
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Serum interleukin-37 and its gene polymorphism (rs3811047) in Egyptian patients with alopecia areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Not just thinning: A case of alopecia universalis after mild COVID-19
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- A clinical study on alopecia areata
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Alopecia Areata in Skin of Color: Trichoscopic Analysis in Black/African American Patients
- Update on pulse corticosteroid therapy for the management of alopecia areata
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study